Header Logo

Connection

GUILLERMINA LOZANO to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications GUILLERMINA LOZANO has written about Drug Evaluation, Preclinical.
GUILLERMINA LOZANO
Connection Strength
0.187
Drug Evaluation, Preclinical
  1. The mutant p53 mouse as a pre-clinical model. Oncogene. 2013 Sep 12; 32(37):4325-30.
    View in: PubMed
    Score: 0.094
  2. Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy. Clin Cancer Res. 2013 Jan 01; 19(1):34-41.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.